4.3 Article

The Impact of Cigarette Smoking on Asthma: A Population-Based International Cohort Study

期刊

出版社

KARGER
DOI: 10.1159/000330900

关键词

Asthma; Cigarette smoking; Epidemiology

资金

  1. ECRHS I for centres in ECRHS II: Belgian Science Policy Office
  2. Ministere de la Sante, Glaxo France
  3. Insitut Pneumologique d'Aquitaine
  4. Contrat de Plan Etat-Region Languedoc-Rousillon
  5. CNMATS
  6. CNMRT [90MR/10, 91AF/6]
  7. Ministre delegue de la sante, RNSP, France
  8. GSF
  9. Bundesministerium fur Forschung und Technologie, Bonn, Germany
  10. Ministero dell'Universita e della Ricerca Scientifica e Tecnologica
  11. CNR
  12. Regione Veneto RSF Italy [381/05.93]
  13. Norwegian Research Council [101422/310]
  14. Dutch Ministry of Wellbeing, Public Health and Culture, The Netherlands
  15. Ministero Sanidad y Consumo Fondo de Investigaciones Santarias [91/0016060/00E-05E, 93/0393]
  16. Hospital General de Albacete
  17. Hospital General Juan Ramon Jimenez
  18. Consejeria de Sanidad Principado de Asturias, Spain
  19. Swedish Medical Research Council
  20. Swedish Heart Lung Foundation
  21. Swedish Association against Asthma and Allergy
  22. Swiss National Science Foundation [4026-28099]
  23. National Asthma Campaign
  24. British Lung Foundation
  25. Department of Health, South Thames Regional Health Authority, UK
  26. United States Department of Health, Education and Welfare Public Health Service [2 S07 RR05521-28]
  27. European Commission
  28. ECRHS II
  29. Albacete, Spain: Fondo de Investigaciones Santarias [97/0035-01, 99/0034-01, 99/0034-02]
  30. Hospital Universitario de Albacete, Consejeria de Sanidad
  31. Antwerp, Belgium: FWO (Fund for Scientific Research)-Flanders Belgium [G.0402.00]
  32. University of Antwerp
  33. Flemish Health Ministry
  34. Barcelona, Spain: SEPAR, Public Health Service [R01 HL62633-01]
  35. Fondo de Investigaciones Santarias [99/0034-02, 97/0035-01,99/0034-01]
  36. CIRIT [1999SGR 00241]
  37. Basel, Switzerland: Swiss National Science Foundation
  38. Swiss Federal Office for Education Science
  39. Swiss National Accident Insurance Fund (SUVA)
  40. Bergen, Norway: Norwegian Research Council, Norwegian Asthma & Allergy Association, Glaxo Wellcome AS, Norway Research Fund
  41. Erfurt, Germany: GSF - National Research Centre for Environment & Health, Deutsche Forschungsgemeinschaft [FR 1526/1-1]
  42. Hamburg, Germany: GSF - National Research Centre for Environment & Health, Deutsche Forschungsgemeinschaft [MA 711/4-1]
  43. Huelva, Spain: Fondo de Investigaciones Santarias [97/0035-01, 99/0034-01, 99/0034-02]
  44. Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble
  45. Ministere de l'Emploi et de la Solidarite, Direction Generale de la Sante, Aventis (France)
  46. Spain: Fondo de Investigaciones Santarias [97/0035-01, 99/0034-01, 99/0034-02]

向作者/读者索取更多资源

Background: The prevalence rates of smoking in subjects with asthma have frequently been reported as similar to those in the general population; however, available data are not up-to-date. There is only limited and somewhat conflicting information on the long-term effects of smoking on health outcomes among population-based cohorts of subjects with asthma. We aimed to investigate changes in smoking habits and their effects on forced expiratory volume in 1 s (FEV1) in subjects with asthma in comparison with the rest of the population, focusing on the healthy smoker effect. Methods: We studied 9,092 subjects without asthma and 1,045 with asthma at baseline who participated in both the European Community Respiratory Health Survey I (20-44 years old in 1991-1993) and 11 (1999-2002). Results: At follow-up, smoking was significantly less frequent among subjects with asthma than in the rest of the population (26 vs. 31%; p < 0.001). Subjects with asthma who were already ex-smokers at the beginning of the follow-up in the 1990s had the highest mean asthma score (number of reported asthma-like symptoms, range 0-5), probably as a result of the healthy smoker effect (2.80 vs. 2.44 in never smokers, 2.19 in quitters and 2.24 in smokers; p < 0.001). The influence of smoking on FEV1 decline did not depend on asthma status. Smokers had the highest proportion of subjects with chronic cough/phlegm (p < 0.01). Conclusion: One out of 4 subjects with asthma continues smoking and reports significantly more chronic cough and phlegm than never smokers and ex-smokers. This stresses the importance of smoking cessation in all patients with asthma, even in those with less severe asthma. Copyright (C) 2012 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据